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Summary 
Gene transfer to chondrocytes followed by intra-articular transplantation may allow for functional modulation of 
chondrocyte biology and enhanced repair of damaged articular cartilage. We chose to examine the loss of chondrocytes 
transduced with a recombinant adenovirus containing the gene for Escherichia col; ~-galactosidase (Ad.RSVntlacZ), 
followed by transplantation i to deep and shallow articular cartilage defects using New Zealand White rabbits as an 
animal model. A type I collagen matrix was used as a carrier for the growth of the transduced chondrocytes and to 
retain the cells within the surgically created articular defects. Histochemical nalysis of matrices recovered from the 
animals 1, 3 and 10 days after implantation showed the continued loss of lacZ positive chondrocytes. The number of 
cells recovered from the matrices was also compared with the initial innoculum of transduced cells present within the 
matrices at the time of implantation. The greatest loss of transduced cells was observed in the first 24 h after 
implantation. The numbers of transduced cells present within the matrices were relatively constant between 1 and 
3 days postimplantation, but had progressively declined by 10 days postimplantation. These results suggest hat 
transduction of chondrocytes followed by intra-articular t ansplantation i  this rabbit model may enable us to examine 
the biological effects of focal transgenic overexpression of proteins involved in cartilage homeostasis and repair. 
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Introduction 
TRANSPLANTATION of cu l tured chondrocytes  into 
areas of car t i l age  in jury has shown promise as 
a method to faci l i tate repa i r  of deep ar t icu lar  
defects [1]. The therapeut ic  appl icat ion of this 
technology cont inues to be explored in a series of 
ongoing human tr ials [2]. However ,  many  ques- 
t ions remain  as to the Cellular mechan isms that  are 
responsib le for growth of new t issue into the site 
of the t reated defect. A more comprehens ive  
unders tand ing  of the fate of t ransp lanted  cells and 
analys is  of their  funct ional  b io logy would not only 
provide impor tant  scientif ic in format ion  but would 
also al low implementat ion  of molecu lar  methods 
that  might  a l ter  funct ion of the t ransp lanted  cells 
in order to fac i l i tate appropr ia te  repai r / regener-  
at ion of damaged ar t icu lar  cart i lage.  
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Several  groups have proposed somat ic  cell gene 
t ransfer  as a method to a l ter  the funct ional  b io logy 
of chondrocytes  that  are used for in t ra -ar t icu lar  
t ransp lantat ion  [3-5]. Somat ic  cell gene t ransfer  is 
also an ideal method for mo lecu lar  mark ing  of 
cu l tured chondrocytes  that  can be used sub- 
sequent ly  in t ransp lantat ion  studies. We have  
prev ious ly  descr ibed in vitro exper iments  indicat-  
ing that  t ransduct ion  of chondrocytes  with 
recombinant  adenov i ruses  might  serve as a method 
to achieve focal del ivery of biological ly act ive  
prote ins over  susta ined periods of t ime [3]. 
However,  studies in an imal  models of cart i lage 
in jury are needed before the concept  of t ransp lant -  
ing t ransduced chondrocytes  for modif icat ion of 
cart i lage repa i r  can be realized. 
A major  logist ical  prob lem prevent ing the 
widespread use of chondrocyte  t ransp lantat ion  as 
a therapeut ic  modal i ty  involves the acquis i t ion of 
ar t i cu lar  cart i lage for iso lat ion of chondrocytes.  
The use of auto logous cells for in t ra -ar t icu lar  
t ransp lantat ion  a l though ideal f rom an immuno- 
logical perspect ive,  is often not  a pract ica l  method 
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to obtain adequate numbers of explanted chondro- 
cytes for application to large and/or multiple areas 
of cartilaginous injury. We hypothesized that the 
relatively poor antigen-presenting capacity of 
articular chondrocytes would enable us to test the 
feasibility of using allogeneic ells for transplan- 
tation into deep defects of articular cartilage 
in vivo [6, 7]. In addition, the use of adenovirally- 
transduced allogeneic ells represents an animal 
model of a worst-case scenario of immunological 
effects associated with ex vivo somatic cell gene 
transfer. 
We hypothesized that transduction of chondro- 
cytes with a marker transgene would provide a 
molecular and histochemical means to follow the 
fate of transplanted cells in vivo. In this study, we 
have attempted to model intra-articular chondro- 
cyte transplantation in a way that would enable us 
to address the following questions. What is the fate 
of chondrocytes implanted into a defined deep 
defect? If the transplanted cells do not readily 
survive in the context of a deep defect, then what 
are the kinetics of cell loss? If the transplanted 
cells are destroyed, can we obtain information that 
would enable us to determine the mechanisms of 
cell death? We now present data indicating that 
limits to the successful transplantation f chondro- 
cytes into deep defects primarily involve microen- 
vironmental factors that effect cell loss within the 
initial 24 h after intra-articular t ansplantation. 
Materials and Methods 
ISOLAT ION AND CULTURE OF ART ICULAR 
CHONDROCYTES 
Chondrocytes used in the study were isolated 
from pieces of articular cartilage separated from 
the underlying bone of cadaveric rabbits. The 
cartilage slices were minced finely and then 
digested sequentially with 0.2% testicular 
hyaluronidase (5 min at 37°C), 0.2% trypsin (30 min 
at 37°C), and 0.2% collagenase (1-2 h at 37°C). The 
resulting solutions were strained through sterile 
nylon mesh and centrifuged at 1200g for 10 min. 
The cell pellets were washed twice with Ham's F-12 
medium, resuspended, pooled and centrifuged at 
1000g for 10min. The resulting pellet was 
suspended in F-12 media containing 10% FCS, 
100 u/ml penicillin G sodium, 100 pg/ml strepto- 
mycin sulfate, and 0.25 ~g/ml amphotericin B 
(complete F-12 media). This cell suspension was 
used to establish cell cultures in 25-cm 2 flasks 
(Falcon) at a density of 1-2x 10 ~ cells/flask. The 
cells were maintained at 37°C in a humidified 
atmosphere of 95% air and 5% CO2. The 
chondrocytes used in this study were maintained 
as monolayer cultures for no more than two 
passages, in order to maintain the differentiated 
chondrocyte phenotype. 
RECOMBINANT ADENOVIRUS 
The adenoviral vector used in this study is based 
on a human adenoviral (serotype 5) genomic 
backbone deleted of sequences spanning EIA and 
EIB and a portion of E3 region. This impairs the 
ability of the virus to replicate or transform 
nonpermissive cells [8]. The transgene transcrip- 
tion was driven by the Rous sarcoma virus (RSV) 
LTR and a SV40 polyadenylation sequence cloned 
downstream of the reporter [9, 10]. The vector 
Ad.RSVntlacZ contains a nuclear targeting (desig- 
nated as nt) epitope linked to the 5' end of the lacZ 
gene, and as result, the cells transduced with this 
gene can be identified by the presence of blue 
nuclei after reaction with the chromogenic 
substrate X-gal. 
TRANSDUCTION OF CHONDROCYTES 
Primary rabbit chondrocyte cultures were 
trypsinized and split 1:4, and allowed to grow to 
70% con fluency in 75 cm 2 flasks. After the cells 
were 70% confluent, they were washed two times 
with serum-free Dulbecco's minimum essential 
medium (DMEM), infected with Ad.RSVntlacZ 
(viral titers=101° plaque forming units (pfu)/ml; 
diluted 1:100 in serum free DMEM) at an 
approximate multiplicity of infection (MOI) of 103 
pfu/cell, for 2 h at 37°C. Cells were then washed 
two times in fresh complete F-12 medium and 
allowed to grow for 24 h at 37°C. Mock infected 
cells were maintained in parallel. 
PREPARATION OF CHONDROCYTE-COLLAGEN IMPLANTS 
We used Helistate absorbent collagen type I 
hemostatic sponges (Intragra Life Sciences Co., 
Plainsboro, NJ, U.S.A.) as a carrier for growth of 
transduced chondrocytes and implantation to 
shallow and deep defects in the rabbit knee. Type 
I collagen implants have previously been shown 
to be a suitable carrier for transplantation of
rabbit chondrocytes into articular defects [11]. Bio- 
mechanical, biochemical and histological analyses 
of chondrocyte containing matrices maintained 
in culture for 6 weeks indicate that the cells 
remain phenotypically stable, metabol ical ly ac- 
tive, secrete g]ycosaminoglycans i to the extra- 
cellular matrix and form an organized pericellular 
matrix. Using a 5 mm skin biopsy punch, discs were 
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obtained from a sheet of collagen sponge and 
sterilized using ethylene oxide before application 
of the chondrocytes. A disc was placed into each 
well of a 96-well plate, and covered with 100 pl 
complete F-12 medium containing 7x 105 chondro- 
cytes. Cells were allowed to adhere to the matrix 
for a period of 7-10 days before implantation 
in vivo. 
ANIMALS 
New Zealand White rabbits (3 kg in weight, 
pasteurella free, HRP, Inc., Kalamazoo, MI, 
U.S.A.) were individually housed in stainless teel 
caging in an AAALAC accredited facility. Rooms 
were environmentally controlled to provide a 
temperature between 61 ° and 71°F, a relative 
humidity of 35-65%, 100% fresh air at a rate of 
10-12 room exchanges per hour, a l ight:dark cycle 
of 12:12h. The rabbits were fed ad libitum a 
designated amount of chow (Purina High Fiber 
Rabbit Chow 5326, St. Louis, MO, U.S.A.). All 
procedures that used animals were conducted in 
compliance with federal laws and guidelines 
established by the Parke-Davis animal care and 
use committee. 
SURGICAL PROCEDURE 
Animals were anesthetized with a single subcu- 
taneous dose of 60mg/kg Vetalar (Forte Dodge 
Laboratories Inc., Fort Dodge, IA, U.S.A.) and 
6 mg/kg Rompun (Miles Inc., Shawnee Mission 
KA, U.S.A.). Supplemental inhalational anesthesia 
with AErrane (Aryquest, BOC Inc., Madison 
WI, U.S.A.) was used as needed. The hair around 
the knee was clipped and the skin was prepped for 
a sterile procedure. Using sterile technique, a 
lateral parapatellar arthrotomy was performed, 
and the patella was luxated medially. A steel 
drill bit (3 mm in diameter) and a dual torque low 
speed drill (Micro Mark) were used to create 
defects in the articular cartilage of the trochlear 
groove. Two types of defects Were created. A deep 
defect (approximately 2 mm) penetrated the carti- 
lage creating a well-circumscribed hole that 
exposed the cortical bone. Bleeding from the 
cortical bone was common. A shallow defect simply 
removed enough of the cartilage and bone to 
create an indentation deep enough to contain 
the implant. The collagen-chondrocyte implants 
were press-fitted into the defects. No additional 
materials or adhesives were applied to the 
matrices, the sponges were held in place within the 
defects by repositioning of the patella within the 
trochlear groove. One simple interrupted cruciate 
3-0 Maxon suture (Davis & Geck Inc., American 
Cyanamid Co., Manati, Puerto Rico) was used to 
close the joint capsule. The skin was closed with 
5-0 PDS II (Ethicon Inc., Johnson & Johnson Co., 
Somerville NJ, U.S.A.) sutures in a simple 
interrupted pattern. 
TISSUE ANALYSES 
Animals  were  euthanized 1, 3 or 10 days after 
implantat ion and  tissue present within the articu- 
lar defects was  removed en bloc. Samples  of defect 
tissue obtained at each t ime point were  used for 
immediate  isolation of adherent  cells. Samples  
were  rinsed briefly in phosphate-buffered saline 
(PBS)  then digested 4 mg/ml  col lagenase (10 min  at 
37°C) then with 0 .5% trypsin and  0 .02% EDTA 
(30rain at 37°C), and  cells were  isolated by 
centrifugation. Cells were  immediate ly  fixed in 2% 
para formaldehyde  in 100ram P IPES  pH6.9  for 
30 min, washed for 30 min  in PBS/2  mM MgCl2  and  
reacted in 5 mM K~Fe(CN)6, 5 mM K4Fe(CN)~, 2 mM 
MgC12 0.01% sodium deoxycholate, 0.02% NP-40, 
and 1 mg/ml 5-bromo-4-chloro-3-indolyl-~-D-galac- 
toside in PBS (X-gal solution) for i h at 37°C [12]. 
Cells were then washed three times with PBS, 
post-fixed for 2h in 2% paraformaldehyde/1% 
glutaraldehyde. The number of lacZ positive cells 
present in the samples was determined by 
identification of blue staining cells using light 
microscopy and a hemocytometer. 
Parallel samples were either returned to sus- 
tained in vitro culture conditions for a period of 5 
days, or were fixed and stained for lacZ expression, 
and frozen in OCT (Sigma). Serial transverse 
sections (7-9~m) were obtained from frozen 
samples using a Leitz 1720 digital cryostat. 
Sections were counterstained with either hema- 
toxylin and eosin, or Picrosirius red, using the 
procedure described by Dolber and Spach, then 
examined by light microscopy and representative 
photomicrographs were obtained (Vanox AHBS 3, 
Olympus Inc.) [13]. 
Resu l ts  
The initial step in this study was to determine 
the growth and viability of adenovirally-trans- 
duced cells seeded onto the surface of type I 
collagen matrices in vitro. Chondrocytes within 
the matrices were compared irectly with mono- 
layer cultures maintained in parallel. Cells were 
seeded at a density of 1.6 x 10~/implant, as well as 
1.6 x 105/well (96 well plate). After 48 h growth the 
mean number of cells recovered from the implants 
was 10.1( + 0.4)x104 and from the plastic plates 
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1314(+ 0.7)x104 per well. The number  of cells 
recovered after 9 days in cul ture were 13.7 x 104 and 
15.5x104 from the matr ices  and plast ic wells, 
respectively.  
Adenovi ra l ly  t ransduced cells were then seeded 
onto a set of matr ices  at  a dose of 7.0x10 ~ lacZ 
posit ive cells per disc. A subset of these matr ices  
were mainta ined  as in vitro cul tures for a per iod of 
10 days. Samples of matr ix  were examined after  1, 
3 and 10 days of culture,  and the tota l  number  of 
lacZ-expressing cells was determined.  The mean 
number  of lacZ-posit ive cells was 1.0 (_+ 0.2) x 105 on 
day 1, 1.1 (___0.5)x105 on day 3 and 0.5 (_+0.07)x105 
on day 10. A l though fewer lacZ-posit ive cells were 
recovered on day 10, these changes were not  
stat is t ica l ly  signif icant. 
The k inet ics of cell g rowth  wi th in  the matr ix  
approx imated  those observed in mono layer  cul- 
tures  of ar t icu lar  chondrocytes.  Col lagen matr ices  
seeded with the t ransduced cells were also 
analyzed h isto logica l ly  af ter  24 h [Fig. l(a)]. The 
t ransduced (lacZ expressing) chondrocytes  were 
~w 
FIG. 1. Implantation of collagen sponges containing adenovirally-transduced chondrocytes into defined articular 
defects allows for persistence of transduced cells in vivo. (a) Transverse sectional photomicrograph of collagen sponge 
seeded in vitro with Ad.RSVntlacZ-transduced chondrocytes before implantation in vivo. Twenty-four hours after 
application of chondrocytes to the matrix samples were fixed, reacted with X-gal solution, snap frozen and 
cryosectioned. Sections (7 ~m) were counterstained with picrosirius red stain to identify collagen fibers. Note that large 
numbers of lacZ positive cells with blue staining nuclei (transduced chondrocytes) can be seen along the surface of 
the collagen matrix but that few cells can be observed at  depth of greater than approximately 0.1 mm. Bar = 100 ~m. 
Magnification=13.2x. (b) Transverse sectional protomicrograph of collagen matrix seeded in vitro with 
Ad.RSvntlacZ-transduced chondrocytes, recovered 24 h after implantation in vivo. Chondrocytes expressing lacZ (blue 
nuclei) can be observed near the implant border but are substantially decreased in the total number of cells compared 
with the pre-implantation samples (a). These sections were not counterstained. Magnification = 33x. (c) Transverse 
sectional photomicrograph of collagen sponge seeded in vitro with Ad.RSVntlacZ-transduced chondrocytes recovered 
72 h after implantation in vivo. Sections were reacted with X-gal and counterstained with hematoxylin and eosin. 
LacZ-positive chondrocytes continue to be observed in a location proximal to the collagen fibers (pink) of the matrix. 
A large number of red blood cells (arrowheads) are also present hroughout he matrix. Magnification= 132x. (d) 
Transverse sectional photomicrograph of collagen sponge seeded in vitro with Ad.RSVntlacZ-transduced chondrocytes 
recovered 10 days after implantation in vivo. Sections were r acted with X-gal and counterstained with hematoxylin 
and eosin. Compared with samples obtained 72 h after implantation, chondrocytes remain concentrated along the 
implant border. Red blood cells (arrowheads) present within the matrix are decreased in number compared to days 
1 and 3. A few mononuclear cells (arrows) are scattered throughout the.section. Magnification = 66x. 
6000 observed to be present (adherent)  almost exclu- 
sively a long the surface of the matrices. 
The remain ing matr ices were implanted into 
cart i lage defects with in rabbit  knees and al lowed 
to grow in vivo for the same durat ion as the in vitro 
cultures. The number  of lacZ-posit ive cells recov- 
ered after t ransp lantat ion  of matr ices in vivo were 
5 (+ 0.09) × 103 at 1 day, 3.0 (___ 0.09) × 103 at 3 days 
and 0.2(±0.03)×104 at 10 days. The survival  of 
t ransgene xpressing cells in vivo at the histologic 
level is also shown in Fig. 1. At the l ight 
microscopic level, samples obta ined 24 h [Fig. l(b)] 
and 72h [Fig. 1(c)] after implantat ion were 
indist inguishable.  In all samples examined, lacZ- 
expressing cells cont inued to be found along the 
surface of the implanted matr ix  but  were 
great ly reduced in number  compared with pre- 
implantat ion matr ix  [Fig. l(a)]. By 10 days after 
implantat ion [Fig. 1(c)], lacZ-expressing cells 
cont inued to be observed with in the recovered 
matrices. No lacZ-expressing cells were observed 
within the deeper port ions of the matrices, and no 
areas of necrot ic  cells were identif ied at any of the 
t ime points examined. 
The kinet ics of t ransduced chondrocyte  survival  
in vivo are shown in Fig. 2. The greatest  loss of 
viable lacZ-positive cells occurred within 24 h after 
implantat ion of matr ix  into the deep defects 
[Fig. 2(a)], with a mean cell loss approaching 90%. 
Addit ional  cell losses observed from days 2-10 
were not stat ist ical ly significant. Paral le l  controls,  
consist ing of matr ix  seeded with equivalent  
numbers of lacZ-expressing cells, were mainta ined 
in t issue culture condit ions for a period of 3 days, 
and showed no signif icant (percentage based) loss 
of lacZ-positive cells. This suggests that  the loss 
of lacZ-positive cells observed in vivo is not  a 
consequence of t ransduct ion  with a recombinant  
adenovirus,  but is a funct ion of the implantat ion 
procedure itself and or the immediate micro- 
env i ronmenta l  condit ions proximal  to the im- 
p lanted matrix. 
The viabi l i ty of the lacZ-expressing cells 
identif ied by l ight microscopy in the 10-day 
samples was establ ished by recovery of matr ices en 
bloc after 10 days in vivo, fol lowed by t ransfer  to 
cell cu l ture [Fig. 2(b)]. Cells were isolated from the 
explanted matr ices after 5 days of growth in vitro 
and stained for lacZ expression. The number  of 
lacZ cells isolated from the matr ices after 10 days 
in vivo (Fig. 2 Column a), compared with the 
number  isolated from matr ices returned to cell 
cul ture for an addit ional  5 days of growth in vitro 
(Fig. 2 Column b) were not signif icantly different 
(P=0.05).  These results confirm that  the trans- 
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FIG. 2. Recovery of viable transduced chondrocytes from 
collagen matrices after implantation i to deep articular 
cartilage defects in vivo. (a) Collagen matrices were 
seeded in vitro with Ad.RSVntlacZ-transduced chondro- 
cytes (mean=7xl05 lacZ positive cells/matrix) and 
implanted into deep articular defects. Tissue present 
within the defect was recovered 1, 3 or 10 days after 
implantation, digested with collagenase and trypsin, and 
cells were isolated by centrifugation. The number of 
cells expressing lacZ was determined by staining with 
X-gal and counting blue cells with a hemocytometer. Six
animals were examined at each time point. Column 
heights ~epresent mean number of lacZ-positive cells per 
matrix _+ standard error. (b) Cells were isolated from the 
collagen matrices after 10 days of growth in vivo and the 
number of lacZ expressing cells was determined (Column 
a). Parallel samples of cells recovered from matrices 
after 10 days of growth in vivo were returned to 
monolayer culture in vitro for an additional 5days before 
quantification oflacZ positive cells (Column b). Controls 
consisting of seeded matrices were maintained in vitro 
for a period of 10 days before recovery and quantification 
of adherent lacZ positive cells (Column c). Column 
heights represent mean number of lacZ-positive cells per 
matrix ± standard error. Column a, N=4. Columns b 
and c, N= 3. 
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viable for at least 10 days after  implantat ion  into 
deep ar t icu lar  defects in vivo. Viable lacZ-express- 
ing cells present  wi th in  the matr ices  after 10 days 
in vivo.represent 3.8% of the init ial  innoculum, as 
determined by compar ison  with paral le l  contro ls  
mainta ined for the ent i re 10 day per iod in vitro 
(Fig. 2 Column c). In order  to determine whether  
physical  contact  of the t ransduced cells with bone 
marrow cells and/or  immune effector cells present  
in subchondra l  bone were responsib le for the 
in vivo loss of cells f rom the matr ix,  we repeated 
the t ransp lantat ion  exper iments  using a series 
of shal low ( lmm)  ar t i cu la r  defects. The results  
(Fig. 3) indicate that  there is no apparent  
difference between deep and shal low defects with 
regard to the k inet ics of cell surv iva l  or the tota l  
percentage of t ransduced cells that  remain  with in 
the matr ix  after the init ia l  imp lantat ion  procedure  
at 1 or 3 days. 
Discuss ion 
In t ra -ar t icu lar  t ransp lantat ion  of exp lanted 
chondroeytes for the repa i r  of car t i lag inous in jury 










Days in vivo 
FIG. 3. Recovery of viable transduced chondrocytes from 
collagen matrices after implantation into shallow 
articular cartilage defects in vivo. Collagen matrices 
were seeded in vitro with Ad.RSVntlacZ-transduced 
chondroeytes (mean=5.0×10 '5 cells/matrix) and im- 
planted into shallow articular defects (diameter =3 mm). 
Tissue present within the defect was recovered 1 and 3 
days after implantation, digested with collagenase and 
trypsin, and cells were isolated by centrifugation. The 
number of cells expressing lacZ was determined by 
staining with X-gal and counting blue cells with a 
hemocytometer. Three animals were examined at each 
time point. Column heights represent mean number of 
lacZ-positive cells per matrix _+ standard error.• 
scientific question associated with this clinical 
technology concerns the fate of cells introduced 
into the microenv i ronment  of a deep defect. A 
corollary to this is can  genetically modif ied cells be 
successfully introduced into deep articular defects, 
and  can these cells cont inue to express transgenic 
proteins for defined periods of t ime? We have  
determined that in the context of an  acellular 
matr ix  seeded with genetically modif ied cells 
in vitro, the cells can  persist within the micro- 
env i ronment  of a deep defect, and  can cont inue to 
express transgenic protein for at least i0 days. 
Realistic limits to the application of intra-artic- 
ular transplantation of chondrocytes  in humans  
are based on identification of a cost-effective 
source of chondrocytes  for transplantation. In this 
study, we  used cadaveric an imals  as a source of 
allogeneic chondrocytes  and  mode led  a worst-case 
scenario with regards to the immuno log ica l  effects 
that might  be associated with this cellular 
transplantation procedure. These  exper iments  
show that t ransduced allogeneic cells survive for 
at least I0 days after intra-articular transplan- 
tation, and  cont inue to express transger~ic protein 
for the durat ion of their survival in vive. 
Previous studies have  used a per ioste~ cap to 
retain transplanted cells within the confines of the 
full-thickness defect. As  an alternative to the use 
of a periosteal cap, we  examined the use of a type 
I col lagen sponge seeded with t ransduced chondro-  
cytes as a cellular implant  that can fo rm fit to the 
d imens ions  of shal low or deep articular defects. 
Chondrocytes  grown within these matrices are 
metabolical ly active, phenotypical ly stable, and  
express extracellular structural proteins charac- 
teristic of articular cartilage [ii]. The  present 
findings suggest that type I col lagen matrices are 
suitable for use as implantable devices for 
retention of genetically-modified chondrocytes  
prox imal  to deep and  shal low articular defects. 
These  matrices also provide a suitable environ- 
ment  for cont inued viability of t ransduced cells 
in vivo. 
We hypothesized that the use of these matrices 
wou ld  increase the potential for cell survival 
compared  with introduction of recently-trypsinized 
cells into a mic roenv i ronment  filled with 
serum, bone  marrow components  and  differenti- 
ated white blood cells. This approach  is also 
technically much simpler and  less invasive than 
the use of the periosteal cap. In addition, the 
matr ix  is b iodegradable and  is gradually replaced 
by new extracellular matr ix  proteins secreted by 
the transplanted cells. Unfortunately, compared  
with matrices seeded with t ransduced chondro- 
cytes and  mainta ined  in vitro, approximate ly  90% 
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of the cells adherent to the matrices were lost after 
24 h in vivo. 
Our data indicates that the major loss of 
transduced chondrocytes from the matrix (approxi- 
mately 90%) occurs within the first 24h after 
implantation. Subsequent rates of loss betwen 1-10 
days were minimal. This kinetic profile indicating 
relatively rapid cell loss within the initial 24 h 
would argue against a mechanism for cell death 
involving cell-mediated cytotoxicity [major histo- 
compatibility complex (MHC) II-restricted cyto- 
toxic T cells] or pathways involving humoral 
immune responses. It also suggests that similar 
rate of transplanted cell death may occur after the 
introduction of autologous chondrocytes into deep 
defects covered by a periosteal cap. The data 
presented by Kang et al. [14] are consistent with 
our observations, and also argue against host 
immunity as the primary mechanism responsible 
for loss of transplanted cells in vivo over the first 
three days. Clearly the identification of a mono- 
nuclear cell infiltrate within the matrix 10 days 
after implantation [Fig. l(d)], is consistent with a 
host immune r sponse directed against allogeneic 
cells and/or transduced cells expressing low levels 
of adenoviral proteins or E. coli ~-galactosidase. 
An alternative xplanation for the rapid loss of 
cells would be that transplanted cells migrated out 
of the matrix and onto the surface of the 
subchondral bone or deeper layers of articular 
cartilage exposed during the surgical creation of 
the defects. Chondrocytes maintained in mono- 
layer culture do acquire a fibroblastic phenotype, 
however, there is no reported evidence of 
dedifferentiated chonrocytes exhibiting a propen- 
sity for functional migration between substrata 
(e.g., collagen matrix to subchondral bone). 
Another alternative explanation for loss of 
transduced cells would be inaccessibility to 
nutrients and/or oxygen at levels necessary to 
maintain cell viability. The hypothesis would be 
that transduced cells present in the interior of the 
matrix at the time of transplantation, or cells that 
migrated into the interior of the collagen matrix 
after in vivo transplantation would be in a 
microenvironment characterized byrelatively slow 
(poor) exchange of gases and small molecules and 
susceptible to death. Our in vitro method for 
seeding the collagen matrix allows for adherence 
and growth of cells on the exterior surface of the 
collagen matrix. Our lacZ gene marking studies 
have shown no evidence to suggest hat cells can 
migrate into the interior of the collagen matrix 
(Fig. 1). We also did not see evidence of necrotic 
cells present within the interior of matrices 
recovered 24 or 72 h after in vivo implantation. The 
fact that relatively-stable numbers of cells remain 
within the matrix between 24 and 72 h would also 
suggest hat ischemic necrosis is not the major 
factor associated with the rapid rate of cell loss 
observed in vivo. 
It is also possible that cells continue to exist 
within the matrix, or within the physical confines 
of the surgical defect, but that extinction of 
transgene xpression renders the cells invisible to 
histochemical staining and identification by light 
microscopy. The vector systems used a retroviral 
long terminal repeat (LTR) to drive transgene 
expression. Although transcriptional silencing of 
LTR promoters in transduced cells has been 
reported to occur after transplantation of cells 
in vivo, it is difficult to invoke promoter 
inactivation that occurs within period of 24 h as a 
mechanism for loss of lacZ-positive cells [15-17]. In 
addition the half life of transgenic lacZ would also 
argue in favor of cell death as the mechanism 
responsible for the loss of X-gal-positive cells. The 
fact that we could readily recover transduced cells 
from the matrix, and that these cells continued to 
express lacZ in vitro (both immediately and after 
sustained monolayer culture), argues strongly 
against the hypothesis that loss of transgene 
expression can explain the rapid loss of lacZ 
positive cells that we observed in vivo. Also the 
kinetics of cell loss in vivo appear to be 
independent of the vector system used for cellular 
transduction. 
We favor the hypothesis that mechanical forces 
transmitted through (impact loading) and/or along 
the edges (shear) of the matrix directly effect 
survival of transplanted cells. Although no 
necrotic ells were identified in histologic sections 
of the matrices recovered from the experimental 
animals, it is unclear at this time whether the 
mechanism(s) of chondrocyte death involve necro- 
sis vs apoptosis, and whether these two pathways 
can be distinguished using this in vivo model 
[18 20]. If cell loss is indeed primarily due to the 
effects of mechanical forces acting on the 
transplanted cells, then the use of perioperative 
joint immobilization may enhance cell viability 
in vivo. 
The continued use of genetically-modified chon- 
drocytes for further in vivo studies may enable us 
to answer many of the outstanding questions that 
have arisen regarding the functional biology of 
chondrocytes implanted intoarticular defects. The 
use of chondrocytes transduced to overexpress 
biologically-active proteins may enable us to 
modify the functional biology of articular tissue 
repair along defined pathways of growth and 
differentiation, and will promote the further 
282 Baragi et a l . :  Transplantation of tranduced chondrocytes 
development of this technology as a therapeut ic  
modality. 
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